| Gustavo Adolfo Silva, PHARMD | |
|
1795 2nd St Ste B, Berkeley, CA 94710-1704 | |
| (510) 559-5440 | |
| Not Available |
| Full Name | Gustavo Adolfo Silva |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1795 2nd St Ste B, Berkeley, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205926227 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 45409 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gustavo Adolfo Silva, PHARMD 1795 2nd St Ste B, Berkeley, CA 94710-1704 Ph: (510) 559-5440 | Gustavo Adolfo Silva, PHARMD 1795 2nd St Ste B, Berkeley, CA 94710-1704 Ph: (510) 559-5440 |
News Archive
The U.N.'s World Food Programme (WFP) and Food and Agriculture Organization (FAO) "warned Wednesday that millions of people in South Sudan are facing worsening hunger and called for urgent action to improve food security through adequate food aid and projects to boost agricultural production," the U.N. News Centre reports,
In a study published July 26 online in the journal Diabetes, physician-researchers from University Hospitals Rainbow Babies and Children's Hospital and Case Western Reserve University School of Medicine found that the asthma medication montelukast (brand name Singulair) can inhibit early changes in diabetic retinopathy, the eye disease which develops due to diabetes, in a mouse model of type 1 diabetes.
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
University of Arizona researchers may have found a way to deliver chemotherapeutic drugs to cancer tissues in controlled doses without harming healthy body cells.
People who report that they have a slower walking pace have a lower life expectancy than fast walkers, according to a new study conducted by researchers at the National Institute for Health Research Leicester Biomedical Research Centre - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University.
› Verified 3 days ago
Ms. Rizza Vanessa Alcaria, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1607 Shattuck Ave, Berkeley, CA 94709 Phone: 510-423-9430 Fax: 510-423-9436 | |
Eileen Brigid Doyle, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2187 Shattuck Ave, Berkeley, CA 94704 Phone: 510-982-3727 Fax: 510-982-3737 | |
Dr. Efren A Bose Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2222 Bancroft Way, Berkeley, CA 94720 Phone: 510-642-3249 Fax: 510-642-5759 | |
Dr. Pamela Gumbs, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2929 Telegraph Ave, Berkeley, CA 94705 Phone: 510-508-4942 Fax: 510-843-0308 | |
John Quoc Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1050 Gilman St, Berkeley, CA 94710 Phone: 510-528-8274 | |
Shirley Wong, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1607 Shattuck Ave, Berkeley, CA 94709 Phone: 510-423-9430 | |
Erin Bufalini, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2190 Shattuck Ave, Berkeley, CA 94704 Phone: 510-849-4691 |